Ampliphi Biosciences Corp (NYSE:APHB) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 974,681 shares, a decline of 2.6% from the August 15th total of 1,001,044 shares. Approximately 11.4% of the shares of the stock are sold short. Based on an average trading volume of 104,382 shares, the days-to-cover ratio is currently 9.3 days.
Ampliphi Biosciences Corp (NYSE:APHB) opened at 1.01 on Friday. The firm’s market capitalization is $8.84 million. The firm has a 50-day moving average of $0.85 and a 200 day moving average of $1.08. Ampliphi Biosciences Corp has a 12-month low of $0.30 and a 12-month high of $38.25.
ILLEGAL ACTIVITY NOTICE: This report was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://ledgergazette.com/2017/09/17/ampliphi-biosciences-corp-aphb-short-interest-update.html.
Ampliphi Biosciences Corp Company Profile
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related companies with MarketBeat.com's FREE daily email newsletter.